Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
N-acetyl Selank Amidate
Overview
N-acetyl Selank Amidate is a synthetic heptapeptide analog of the immunomodulatory peptide tuftsin, modified with acetylation and amidation to increase half-life and central nervous system activity. It is reported to exert anxiolytic and nootropic effects through modulation of enkephalin metabolism and influencing monoamine neurotransmitter systems without sedation or dependency.
Mechanism of Action
The peptide has been explored for anxiety, cognitive enhancement, and stress adaptation.
Research Summary & Key Findings
Preclinical studies in rodents have shown anxiolytic effects comparable to benzodiazepines but without adverse effects on motor coordination or memory, with publications in behavioral pharmacology journals. Small clinical studies conducted in Russia have reported subjective improvements in anxiety and cognitive performance, but these lack the rigor and replication of international randomized trials. The compound is not approved by major Western regulatory agencies.
Clinical Status
N-acetyl Selank Amidate is in the investigational stage. While preclinical and early-phase data exist, it has not received regulatory approval for clinical use in the United States.
Administration Routes
References
Primary literature
- PubMed: "N-acetyl Selank Amidate"
Peer-reviewed literature indexed by the National Library of Medicine.
- ClinicalTrials.gov: "N-acetyl Selank Amidate"
Registered interventional and observational studies, including status and phase.
- PubChem: "N-acetyl Selank Amidate"
Chemical structure, molecular properties, and bioactivity data.
Study-level citations for this compound are being verified against the primary sources before publication. The database queries above return the current indexed literature in the meantime.
Related Peptides in Cognitive
Semax
InvestigationalA synthetic heptapeptide analog of the ACTH(4-7) fragment (Met-Glu-His-Phe-Pro-Gly-Pro) with nootropic and neuroprotecti...
View detailsSelank
InvestigationalA synthetic analog of the endogenous tetrapeptide tuftsin (Thr-Lys-Pro-Arg) with an added Pro-Gly-Pro sequence for stabi...
View detailsCerebrolysin
InvestigationalA porcine brain-derived peptide preparation consisting of low-molecular-weight neuropeptides and free amino acids that m...
View detailsP21 (Peptide)
Research PhaseA small synthetic peptide derived from the active region of ciliary neurotrophic factor (CNTF) designed to promote neuro...
View detailsNo lawful pathway today
N-acetyl Selank Amidate is not FDA-approved and does not currently have a lawful prescription or compounding pathway in the United States, so there is nothing for us to sell you here and no consultation to book. That can change: eight peptides moved back to a lawful pathway in February 2026.
Tell me if the status changes
One email, only if this compound's regulatory standing actually moves. Not a newsletter, not a sales sequence.
Join the Association
Access exclusive peptide protocols, provider resources, and community support.
List Your PracticeDisclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol. See our editorial policy for how this content is produced and reviewed.